Signal Identification in Addictovigilance: the Functioning of the French System
Therapie, 70 2 (2015) 123-131
Publié en ligne : 2015-04-09
Article cité par
La fonctionnalité Article cité par… liste les citations d'un article. Ces citations proviennent de la base de données des articles de EDP Sciences, ainsi que des bases de données d'autres éditeurs participant au programme CrossRef Cited-by Linking Program. Vous pouvez définir une alerte courriel pour être prévenu de la parution d'un nouvel article citant " cet article (voir sur la page du résumé de l'article le menu à droite).
Article cité :
Citations de cet article :
Monitoring misuse and abuse of psychoactive substances in France: Insights from substance abuse treatment facilities through the OPPIDUM program
Clémence Lacroix, Elisabeth Frauger, Elisabeth Jouve, Hélène Peyrière and Joëlle MicallefTherapies 80 (2) 177 (2025)
https://doi.org/10.1016/j.therap.2024.10.054
Sex/gender differences in spontaneous reports to a French Addictovigilance centre
Héléne Peyriére, Ange Dampierre, Roselyne Vallo, Margot Lestienne, Céline Eiden and Héléne DonnadieuArchives of Women's Mental Health 28 (1) 191 (2025)
https://doi.org/10.1007/s00737-024-01486-6
Inputs of pharmacoepidemiology in addictovigilance: How do they fit together?
Thomas Soeiro, Amélie Daveluy, Caroline Victorri-Vigneau, Maryse Lapeyre-Mestre and Joëlle MicallefTherapies 80 (2) 205 (2025)
https://doi.org/10.1016/j.therap.2024.10.058
Addictovigilance: The Edge of reason?
Maryse Lapeyre-Mestre, Joelle Micallef, Amélie Daveluy, Reynald Le Boisselier, Célian Bertin, Nathalie Fouilhe Sam-Lai, Régis Bordet, Alexandra Boucher, Joëlle Micallef, Hélène Peyrière, Pierre Gillet, Caroline Victorri-Vigneau, Anne Batisse, Marie-Christine Perault-Pochat and Maryse Lapeyre-MestreTherapies 80 (2) 155 (2025)
https://doi.org/10.1016/j.therap.2025.01.001
Contribution of Addictovigilance data to assess adverse‐events linked to psychoactive substances in children and adolescents
Hélène Peyrière, Anne Batisse, Nathalie Fouilhé Sam‐Laï, Amélie Daveluy, Christine Fournier‐Choma, Sylvie Deheul, Cécile Chevalier, Clémence Lacroix, Valérie Gibaja, Aurélie Aquizerate, Stéphanie Pain, Emilie Jouanjus, Marie‐Christine Picot and Erika NogueBritish Journal of Clinical Pharmacology (2025)
https://doi.org/10.1002/bcp.70133
Non-medical use of baclofen: A case series and review of the literature
Jean-Marc Pelerin, Lisa Fristot, Valérie Gibaja, Bruno Revol, Pierre Gillet and Juliana Lima-TournebizeTherapies 78 (6) 615 (2023)
https://doi.org/10.1016/j.therap.2023.02.007
Management of Pregabalin Use Disorder: A Case Series
Lisa Langlumé, Céline Eiden, Sophie Roy, Floriane Taruffi, Julien Gambier, Hélène Donnadieu-Rigole and Hélène PeyrièreJournal of Psychoactive Drugs 54 (4) 386 (2022)
https://doi.org/10.1080/02791072.2021.2013579
Adverse events of recreational cannabis use during pregnancy reported to the French Addictovigilance Network between 2011 and 2020
Emilie Bouquet, Céline Eiden, Bernard Fauconneau, Charlotte Pion, Carton Louise, Chevalier Cécile, Daveluy Amélie, Fournier-Choma Christine, Heredia Julie, Istvan Marion, Jouanjus Emilie, Peyrière Hélène, Pochard Liselotte, Revol Bruno, Savignat Véronique, Tournebize Juliana, Stéphanie Pain and Marie-Christine Pérault-PochatScientific Reports 12 (1) (2022)
https://doi.org/10.1038/s41598-022-19197-2
Increase of high‐risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data
Anne Roussin, Thomas Soeiro, Charlotte Fouque, Emilie Jouanjus, Elisabeth Frauger, Nathalie Fouilhé, Michel Mallaret, Joëlle Micallef and Maryse Lapeyre‐MestreBritish Journal of Clinical Pharmacology 88 (8) 3789 (2022)
https://doi.org/10.1111/bcp.15323
Safety concerns on the abuse potential of esketamine: Multidimensional analysis of a new anti‐depressive drug on the market
Jules Baudot, Thomas Soeiro, Marine Tambon, Nicolas Navarro, Gwenaëlle Veyrac, Salim Mezaache and Joëlle MicallefFundamental & Clinical Pharmacology 36 (3) 572 (2022)
https://doi.org/10.1111/fcp.12745
Ten‐year trends in hospitalizations related to cocaine abuse in France
Céline Eiden, Sophie Roy, Nicolas Malafaye, Michel Lehmann and Hélène PeyrièreFundamental & Clinical Pharmacology 36 (6) 1128 (2022)
https://doi.org/10.1111/fcp.12815
Opioid misuse in community pharmacy patients with chronic non‐cancer pain
Camille Philip, Sophie Roy, Céline Eiden, Marion Soler, François Georgin, Agnès Müller, Marie‐Christine Picot, Helene Donnadieu‐Rigole and Hélène PeyriereBritish Journal of Clinical Pharmacology 88 (5) 2306 (2022)
https://doi.org/10.1111/bcp.15164
Antidepressants abuse in subjects with opioid use disorders: A 10‐year study in the French OPPIDUM program
Robinson Gravier Dumonceau, Thomas Soeiro, Clémence Lacroix, Adeline Giocanti, Élisabeth Frauger, Salim Mezaache and Joëlle MicallefFundamental & Clinical Pharmacology 36 (2) 436 (2022)
https://doi.org/10.1111/fcp.12738
Chemsex practice in France: An update in Addictovigilance data
Anne Batisse, Céline Eiden, Sylvie Deheul, Emilie Monzon, Samira Djezzar and Hélène PeyrièreFundamental & Clinical Pharmacology 36 (2) 397 (2022)
https://doi.org/10.1111/fcp.12725
Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance Network
Thomas Soeiro, Clémence Lacroix, Vincent Pradel, Maryse Lapeyre-Mestre and Joëlle MicallefFrontiers in Psychiatry 12 (2021)
https://doi.org/10.3389/fpsyt.2021.640120
Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance
Marine Tambon, Camille Ponté, Emilie Jouanjus, et al.Frontiers in Psychiatry 12 (2021)
https://doi.org/10.3389/fpsyt.2021.639780
Pharmaciens d’officine, étudiants en pharmacie et demandes de médicaments à base de codéine : étude observationnelle
Marie Baumevieille, Agathe Rambaud, Joëlle Perri-Plande and Amélie DaveluyTherapies 75 (6) 569 (2020)
https://doi.org/10.1016/j.therap.2019.12.006
Consumption of psychoactive substances in prison: Between initiation and improvement, what trajectories occur after incarceration? COSMOS study data
Morgane Rousselet, Marylène Guerlais, Pascal Caillet, et al.PLOS ONE 14 (12) e0225189 (2019)
https://doi.org/10.1371/journal.pone.0225189
Early signal of diverted use of tropicamide eye drops in France
Camille Ponté, Christian Pi, Aurore Palmaro, Emilie Jouanjus and Maryse Lapeyre‐MestreBritish Journal of Clinical Pharmacology 83 (8) 1791 (2017)
https://doi.org/10.1111/bcp.13272
Poisoning by synthetic cathinones: Consumption behaviour and clinical description from 11 cases recorded by the Addictovigilance Centre of Bordeaux
Amélie Daveluy, Magali Labadie, Karine Titier, et al.Toxicologie Analytique et Clinique 29 (1) 34 (2017)
https://doi.org/10.1016/j.toxac.2016.11.005
Identifying Life-Threatening Admissions for Drug Dependence or Abuse (ILIADDA): Derivation and Validation of a Model.
Tri-Long Nguyen, Thierry Boudemaghe, Géraldine Leguelinel-Blache, Céline Eiden, Jean-Marie Kinowski, Yannick Le Manach, Hélène Peyrière and Paul LandaisScientific Reports 7 (1) (2017)
https://doi.org/10.1038/srep44428
Décès en relation avec l’abus de médicaments et substances (Drames) : focus en région Languedoc-Roussillon
W. Champeau, C. Eiden, O. Mathieu, et al.La Revue de Médecine Légale 7 (4) 137 (2016)
https://doi.org/10.1016/j.medleg.2016.08.003
Usage de psychostimulants dans un contexte sexuel : analyse des cas rapportés au Réseau français des centres d’addictovigilance. Évaluation des risques liés à la pratique du SLAM
Anne Batisse, Hélène Peyrière, Céline Eiden, Marie-Anne Courné and Samira DjezzarTherapies 71 (5) 447 (2016)
https://doi.org/10.1016/j.therap.2016.04.003
Withdrawal syndrome after co-medication of opioid maintenance therapy with nalmefene: unrecognized interaction
Caroline Diot, Céline Eiden, Anne Roussin, et al.European Journal of Clinical Pharmacology 71 (12) 1539 (2015)
https://doi.org/10.1007/s00228-015-1931-y